ArticleInternational journal of molecular sciences2026

Clinical Outcomes and Exploratory Longitudinal CTL/Vβ Repertoire Remodeling in Patients with Relapsed or Refractory Large B-Cell Lymphoma and Follicular Lymphoma Treated with Epcoritamab.

Tatsuro Jo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.